134 related articles for article (PubMed ID: 17426710)
1. Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy.
Elojeimy S; Liu X; McKillop JC; El-Zawahry AM; Holman DH; Cheng JY; Meacham WD; Mahdy AE; Saad AF; Turner LS; Cheng J; A Day T; Dong JY; Bielawska A; Hannun YA; Norris JS
Mol Ther; 2007 Jul; 15(7):1259-63. PubMed ID: 17426710
[TBL] [Abstract][Full Text] [Related]
2. Fas ligand gene transfer effectively induces apoptosis in head and neck cancer cells.
Ji X; Jiang C; Liu Y; Bu D; Xiao S
Acta Otolaryngol; 2011 Aug; 131(8):876-81. PubMed ID: 21504271
[TBL] [Abstract][Full Text] [Related]
3. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
Roh JL; Park JY; Kim EH; Jang HJ
Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
[TBL] [Abstract][Full Text] [Related]
4. Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer.
Liu X; Elojeimy S; El-Zawahry AM; Holman DH; Bielawska A; Bielawski J; Rubinchik S; Guo GW; Dong JY; Keane T; Hannun YA; Tavassoli M; Norris JS
Mol Ther; 2006 Nov; 14(5):637-46. PubMed ID: 16887394
[TBL] [Abstract][Full Text] [Related]
5. FasL gene therapy: a new therapeutic modality for head and neck cancer.
ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS
Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918
[TBL] [Abstract][Full Text] [Related]
6. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.
Mahdy AE; Cheng JC; Li J; Elojeimy S; Meacham WD; Turner LS; Bai A; Gault CR; McPherson AS; Garcia N; Beckham TH; Saad A; Bielawska A; Bielawski J; Hannun YA; Keane TE; Taha MI; Hammouda HM; Norris JS; Liu X
Mol Ther; 2009 Mar; 17(3):430-8. PubMed ID: 19107118
[TBL] [Abstract][Full Text] [Related]
7. Acid ceramidase inhibition: a novel target for cancer therapy.
Liu X; Elojeimy S; Turner LS; Mahdy AE; Zeidan YH; Bielawska A; Bielawski J; Dong JY; El-Zawahry AM; Guo GW; Hannun YA; Holman DH; Rubinchik S; Szulc Z; Keane TE; Tavassoli M; Norris JS
Front Biosci; 2008 Jan; 13():2293-8. PubMed ID: 17981711
[TBL] [Abstract][Full Text] [Related]
8. p53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis.
Hara S; Nakashima S; Kiyono T; Sawada M; Yoshimura S; Iwama T; Banno Y; Shinoda J; Sakai N
Cell Death Differ; 2004 Aug; 11(8):853-61. PubMed ID: 15088070
[TBL] [Abstract][Full Text] [Related]
9. The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy.
Saad AF; Meacham WD; Bai A; Anelli V; Elojeimy S; Mahdy AE; Turner LS; Cheng J; Bielawska A; Bielawski J; Keane TE; Obeid LM; Hannun YA; Norris JS; Liu X
Cancer Biol Ther; 2007 Sep; 6(9):1455-60. PubMed ID: 17881906
[TBL] [Abstract][Full Text] [Related]
10. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for the Fas-/Fas-Ligand pathway in chemoresistance of human squamous cell carcinomas of the head and neck (SCCHN)?
Sproll KC; Balló H; Hoffmann TK; Scheckenbach K; Koldovsky U; Balz V; Hafner D; Ramp U; Bier H
Oral Oncol; 2009 Jan; 45(1):69-84. PubMed ID: 18620901
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo.
Gu X; Song X; Dong Y; Cai H; Walters E; Zhang R; Pang X; Xie T; Guo Y; Sridhar R; Califano JA
Clin Cancer Res; 2008 Mar; 14(6):1840-8. PubMed ID: 18347187
[TBL] [Abstract][Full Text] [Related]
13. Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes.
Coe GL; Redd PS; Paschall AV; Lu C; Gu L; Cai H; Albers T; Lebedyeva IO; Liu K
Sci Rep; 2016 Aug; 6():30816. PubMed ID: 27487939
[TBL] [Abstract][Full Text] [Related]
14. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
[TBL] [Abstract][Full Text] [Related]
15. Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells.
Holman DH; Turner LS; El-Zawahry A; Elojeimy S; Liu X; Bielawski J; Szulc ZM; Norris K; Zeidan YH; Hannun YA; Bielawska A; Norris JS
Cancer Chemother Pharmacol; 2008 Feb; 61(2):231-42. PubMed ID: 17429631
[TBL] [Abstract][Full Text] [Related]
16. The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy.
Scheurer MJJ; Brands RC; El-Mesery M; Hartmann S; Müller-Richter UDA; Kübler AC; Seher A
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875877
[TBL] [Abstract][Full Text] [Related]
17. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck.
Masood R; Kumar SR; Sinha UK; Crowe DL; Krasnoperov V; Reddy RK; Zozulya S; Singh J; Xia G; Broek D; Schönthal AH; Gill PS
Int J Cancer; 2006 Sep; 119(6):1236-48. PubMed ID: 16615113
[TBL] [Abstract][Full Text] [Related]
18. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo.
Morales A; París R; Villanueva A; Llacuna L; García-Ruiz C; Fernández-Checa JC
Oncogene; 2007 Feb; 26(6):905-16. PubMed ID: 16862171
[TBL] [Abstract][Full Text] [Related]
20. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.
Li D; Day KV; Yu S; Shi G; Liu S; Guo M; Xu Y; Sreedharan S; O'Malley BW
Cancer Res; 2002 Aug; 62(16):4637-44. PubMed ID: 12183420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]